Description

CJC-1295 + Ipamorelin (Compounded)
Pharmacy Prepared | Made to Order

Total Content: 40 mg combined peptide blend
CJC-1295: 20 mg
Ipamorelin: 20 mg
Concentration: 2000 mcg/mL CJC-1295 + 2000 mcg/mL Ipamorelin
Volume: 10 mL

Typical Use
Dosing is individualised and determined by the prescribing doctor based on your goals, medical history, and overall treatment plan.

A common clinical range:
200 to 300 mcg of the combined blend daily, often split into morning and evening doses

About This Treatment
This compounded peptide blend may be considered by the prescribing doctor as part of a broader, individualised protocol.

Treatment selection is based on clinical assessment, patient history, and practitioner judgement.

Estimated Duration
Approximately 100 days at 200 mcg daily
Approximately 66 days at 300 mcg daily
May vary depending on prescribed dose

Most protocols extend beyond a single vial depending on duration and dosing

Quality and Preparation
Pharmacy compounded to order
Prepared in a sterile, controlled laboratory environment
Batch tested for quality and safety
Produced in line with medical compounding standards

Treatment Oversight
All treatments are prescribed by a licensed doctor
Dispensed by an Australian compounding pharmacy
Guided and monitored appropriately throughout

Important
This is a prescription only treatment and is supplied only where clinically appropriate

Treatment options shown are examples only and are subject to individual medical assessment and approval